StockData

Niki BioSolutions, Inc. (NIKI) stock

NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q4 FY2025, quarter ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.50−0.20 (-11.76%)

Close on Nov 17, 2026Market cap $12.22MP/E –Yield –

Niki BioSolutions total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Niki BioSolutions's total debt was $129.85K at Dec 31, 2022. For fiscal 2022 it was $129.85K, down 56.2% from the year before. The highest annual figure on record is $3.42M in fiscal 2018.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$129.85K-56.2%
FY2021Dec 31, 2021$296.23K0.0%
FY2020Dec 31, 2020$296.23K+0.5%
FY2019Dec 31, 2019$294.61K-91.4%
FY2018Dec 31, 2018$3.42M+94.4%
FY2017Dec 31, 2017$1.76M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$129.85K-56.2%
Q2 FY2022Jun 30, 2022$295.89K-11.9%
Q4 FY2021Dec 31, 2021$296.23K+0.5%
Q2 FY2021Jun 30, 2021$296.23K-91.3%
Q4 FY2020Dec 31, 2020$296.23K-83.1%
Q2 FY2020Jun 30, 2020$335.88K–
Q4 FY2019Dec 31, 2019$294.61K–
Q4 FY2018Dec 31, 2018$3.42M–
Q4 FY2017Dec 31, 2017$1.76M–

More Niki BioSolutions figures

See a number that looks wrong?